Donald P. Braun
Vice President of Clinical Research
Area of Expertise
- Immunology
- Microbiology
- Inflammatory diseases
- Oncology
- Cancer immunology
- Cancer immunotherapy
Examples of Published Works and Presentations:
- Dmowski WP and Braun DP. Immunology of Endometriosis. Clin. Obst. Gyn. 18: 245-65, 2004.
- Braun, DP, Crist KA, Shaheen F, Staren ED, and Parker J. Aromatase Inhibitors Increase the Sensitivity of Human Tumor Cells to Monocyte-Mediated, Antibody Dependent Cellular Cytotoxicity (MM-ADCC). Amer. J. of Surgery. 190: 570-71, 2005.
- Braun DP, Ding JD, Shaheen F, Willey J, Rana N, and Dmowski WP. Quantitative Expression of Apoptosis Regulating Genes in Endometrium from Women with and without Endometriosis. Fertil and Steril. In press, 2006.
Quote
"Cancer Treatment Centers of America is committed to offering patients new treatment options that go well beyond standard therapy. As an immunologist with a career-long interest in cancer immunotherapy, I am delighted to be part of this effort. My goal is to bring to our patients, highly active, well-tolerated immune therapies and other biologically-based treatments, which can be included as part of the total integrative approach to cancer care that is the hallmark of CTCA."
Bio
Dr. Braun oversees clinical research operations regarding project planning, design, execution, and analysis. He has over 25 year’s research experience in immunology, microbiology, inflammatory diseases, oncology, cancer immunology and cancer immunotherapy. He served on the Experimental Therapeutics Study Section of the National Cancer Institute, the Experimental Immunology and Immunotherapy Study Section of the American Cancer Society (National Division). Most recently he served as the Administrative Director of the Medical College of Ohio Cancer Institute and formerly as the Scientific Director of Rush Cancer Institute.
